10+ can't miss Houston business and innovation events for July

WHERE TO BE

Don't miss these July events — from meetups to hackathons. Photo via Getty Images

From networking meetups to expert speaker summits, July is filled with opportunities for Houston innovators.

Here's a roundup of events you won't want to miss out on so mark your calendars and register accordingly.

Note: This post may be updated to add more events.

July 4 — Houston Blockchain Alliance Monthly Meetup

Check out the Houston Blockchain Alliance Monthly Meetup at The Cannon, in partnership with Lucrisma, Event Horizon Capital, and CryptoEQ. This in-person event is a great opportunity to connect with fellow blockchain enthusiasts in the Houston area. Whether you're a beginner or an expert, come and engage in lively discussions, share insights, and network with like-minded individuals.

This event is Thursday, July 4, from 5:30 to 7:30 pm at The Cannon. Click here to register.

July 9 — Software Day at the Ion: An Intro to Central Texas Seed Stage VCs

Over the course of 2-hours, first-time entrepreneurs looking for guidance or seasoned founders needing help tackling tough challenges will have access to a group of curated mentors from the Mercury network and gain insights and guidance tailored to their needs. Speakers on the panel "An Intro to Central Texas Seed Stage VCs” include: Eric Engineer, S3 Ventures; Rajiv Bala, Clutch Ventures; Cat Dizon, Active Capital; Mike Marcantonio, LiveOak; and moderator Aziz Gilani, Mercury.

This event is Tuesday, July 9, from 3:30 to 7 pm at The Ion. Click here to register.

July 9 — Tech+Tequila Talk: The Future of Tokenization and Capital Raising

Guest speaker, Ed Nwokedi, the Founder and CEO of RedSwan CRE Marketplace will unpack the process of converting ownership rights in an asset into digital tokens on a blockchain, how tokenization allows for fractional ownership, and the impact these innovations can have on capital raising and asset management.

This event is Tuesday, July 9, from 8 to 8 pm at Esperson Building. Click here to register.

July 11 — Out in Tech Mixer

Out in Tech Houston provides an inclusive networking space for LGBTQ+ people and allies working in tech. Check out this relaxed, social-mixer event, hosted on the second Thursday of every month.

This event is Thursday, July 11, from 7 to 8:30 pm at Second Draught. Click here to register.

July 15 — 2024 Young Leaders Institute: Renewable Energy and Climate Solutions

Asia Society Texas' Young Leaders Institute (YLI) is a week-long summer program for high school students that promotes global competence, elevates leadership skills, and connects students from across diverse backgrounds and experiences. The Institute invites students to explore some of the most timely, relevant global issues for young leaders today.

This event starts Monday, July 15, from 8:30 am to 12:30 pm at the Asia Society Texas Center. Click here to register.

July 17 — Open Project Night at Impact Hub Houston

A chance to work on solutions for some of Houston’s most pressing issues, the theme of this month's meeting will be gender equality. Network and workshop pitching materials with likeminded entrepreneurs.

This event is Wednesday, July 17, from 5:30 to 8 pm at 808 Travis St. Click here to register.

July 18 — First of a Kind (FOAK) Networking Lunch

Inspired by the recent FOAK Roundtable hosted by Deanna Zhang, the Energy Underground team of professionals are diving deep into the world of innovative initiatives. Whether you're a seasoned professional or just dipping your toes into the realm of groundbreaking projects, this lunch is for you. The Energy Underground is a group of professionals in the Greater Houston area that are accelerating the Energy Transition.

This event is Thursday, July 18, from 12 to 1 pm at The Cannon West Houston. Click here to register.

July 20 — FIONA: 5th Annual HACKATHON

Get ready for a day filled with coding challenges, teamwork, and innovation. Whether you're a seasoned coder or just starting out, this event is great for anyone passionate about technology and creativity. Go in person a day of brainstorming, coding, and presenting your projects to a panel of judges. Collaborate with fellow hackers, learn new skills, and showcase your talents.

This event is Saturday, July 20, from 11 am to 2 pm at 15500 Voss Rd. Click here to register.

July 24 — Houston Methodist Clinician Speaker Series

Dr. Desai, Vice President, Chief Operating Officer, and Chief Medical Officer & Chief Quality Officer at Houston Methodist Cypress Hospital, will discuss the plans for Houston Methodist's ninth hospital which is scheduled to open in early 2025.

Agenda:

4:30pm - Arrival & Registration

5:00pm - Presentation by Dr. Desai

5:30pm - Audience discussion

6:00pm - Event concludes

This event is Wednesday, July 24, from 4:30 to 6 pm at The Ion. Click here to register.

July 25 — DivInc Demo Day: Sports Tech Spring 2024

The Spring 2024 Sports Tech Demo Day will be a celebration and showcase of the growth of founders using technology to enhance human performance, fan experience, fantasy sports & betting, future of media, NIL innovation (i.e. Name, Image, Likeness), and stadium & venue innovation.

This event is Thursday, July 25, from 6:30 to 7:30 pm at The Ion. Click here to register.

July 30 — Texas Small Business Expo

Texas Small Business Expo is a trade show, educational business to business conference, exhibition & networking event for entrepreneurs, start-ups and anyone who owns a business. Network, build new business relationships, and learn from industry experts on how to enhance your business.

This event is Tuesday, July 30, from 4 to 9 pm at Wakefield Crowbar. Click here to register.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings